What is the incidence of tuberous sclerosis complex (TSC) in twins?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incidence of Tuberous Sclerosis Complex

The incidence of tuberous sclerosis complex (TSC) at birth is approximately 1 in 5,800 live births, affecting over one million patients worldwide. 1

Epidemiological Data

The birth incidence of TSC is well-established across multiple high-quality sources:

  • Primary incidence figure: 1 in 5,800 live births 1
  • Alternative estimates: Research literature reports a range of 1 in 5,000 to 10,000 live births, with some sources citing 1 in 6,000 2, 3, 4, 5, 6

The slight variation in reported incidence likely reflects differences in study populations, diagnostic criteria evolution, and improved detection methods over time. The most recent 2024 guideline consensus supports the 1 in 5,800 figure as the most accurate current estimate. 1

Prevalence vs. Incidence

While the birth incidence is 1 in 5,800, the population prevalence is estimated at approximately 1 in 20,000, which accounts for mortality throughout the lifespan. 2 This discrepancy highlights that TSC carries significant morbidity and mortality risks, particularly from:

  • Epilepsy complications (status epilepticus and sudden unexpected death in epilepsy) 1
  • Kidney disease (the most common cause of death in adults with TSC) 1
  • Infectious complications 1

Genetic Inheritance Pattern

TSC follows an autosomal dominant inheritance pattern, but the majority of cases arise de novo: 7

  • De novo mutations: Two-thirds to three-fourths of all TSC cases result from new mutations 7
  • Inherited cases: Only one-quarter to one-third have an affected parent 7
  • Germline mosaicism risk: Parents of a child with apparently sporadic TSC have a 1-2% risk of having another affected child due to possible germline mosaicism 7

Clinical Recognition Challenges

Despite this relatively high incidence, TSC remains underrecognized in clinical practice because less than 40% of patients present with the classic triad of facial angiofibromata, developmental delay, and intractable epilepsy. 1, 7 This underscores the importance of maintaining clinical suspicion and utilizing both major and minor diagnostic criteria for identification. 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.